Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.87
+0.32 (4.24%)
At close: Nov 7, 2025, 4:00 PM EST
7.66
-0.21 (-2.67%)
After-hours: Nov 7, 2025, 4:21 PM EST
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $204.64 million as of November 7, 2025. Its market cap has decreased by -62.07% in one year.
Market Cap
204.64M
Enterprise Value
73.86M
1-Year Change
-62.07%
Ranking
Category
Stock Price
$7.87
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has decreased from $236.80M to $204.64M, a decrease of -13.58%. That is a compound annual growth rate of -1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 204.60M | -55.05% |
| Dec 31, 2024 | 455.20M | 325.42% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
| Jun 22, 2016 | 236.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |